Pa. Luciw et al., PERSISTENT INFECTION OF RHESUS MACAQUES WITH T-CELL-LINE-TROPIC AND MACROPHAGE-TROPIC CLONES OF SIMIAN HUMAN IMMUNODEFICIENCY VIRUSES (SHIV), Proceedings of the National Academy of Sciences of the United Statesof America, 92(16), 1995, pp. 7490-7494
To elucidate the functions of human immunodeficiency virus type 1 (HIV
-1) genes in a nonhuman primate model, we have constructed infectious
recombinant viruses (chimeras) between the pathogenic molecular clone
of simian immunodeficiency virus (SIV) SIVmac239 and molecular clones
of HIV-1 that differ in phenotypic properties controlled by the env ge
ne, HIV-1(SF33) is a T-cell-fine-tropic virus which induces syncytia,
and HIV-1(SF162) is a macrophage-tropic virus that does not induce syn
cytia, A DNA fragment encoding tat, rev, and env (gp160) of SIVmac239
has been replaced with the counterpart genetic region of HIV-1(SF33) a
nd HIV-1(SF162) to derive chimeric recombinant simian/human immunodefi
ciency virus (SHIV) strains SHIVSF33 and SHIVSF162, respectively, In t
he acute infection stage, macaques inoculated with SHIVSF33 had levels
of viremia similar to macaques infected with SIVmac239, whereas virus
loads were 1/10th to 1/100th those in macaques infected with SHIVSF16
2. Of note is the relatively small amount of virus detected in lymph n
odes of SHIVSF162-infected macaques. In the chronic infection stage, m
acaques infected with SHIVSF33 also showed higher virus loads than mac
aques infected with SHIVSF162 Virus persists for over 1 year, as demon
strated by PCR for amplification of viral DNA in all animals and by vi
rus isolation in some animals. Antiviral antibodies, including antibod
ies to the HIV-1 env glycoprotein (gp160), were detected; titers of an
tiviral antibodies were higher in macaques infected with SHIVSF33 than
in macaques infected with SHIVSF162 Although virus has persisted for
over 1 year after inoculation, these animals have remained healthy wit
h no signs of immunodeficiency, These findings demonstrate the utility
of the SHIV/macaque model for analyzing HIV-1 env gene functions and
for evaluating vaccines based on HIV-1 env antigens.